GOSSAMER BIO, INC. Restricted Cash, Current
GOSSAMER BIO, INC. (GOSS) had Restricted Cash, Current of $0 as of 2022-12-31, per its 10-K filed 2023-03-17.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:RestrictedCashCurrent · last filed 2023-03-17
- 2022-12-31: Restricted Cash, Current $0.00.
- 2022-09-30: Restricted Cash, Current $0.00.
- 2022-06-30: Restricted Cash, Current $0.00.
- 2022-03-31: Restricted Cash, Current $64.00K.
| Period end | Restricted Cash, Current | Restricted Cash, Current as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-17 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $64.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $64.00K 10-K · filed 2023-03-17 | |
| 2021-09-30 | $64.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $566.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $565.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $565.00K 10-K · filed 2022-03-03 | |
| 2019-12-31 | $63.00K 10-K · filed 2021-02-26 | $0.00 10-K · filed 2020-03-24 |
| 2018-12-31 | $200.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |